Radiobiological effect induced by different activities of 125I seed brachytherapy in a hepatocellular carcinoma model

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5260-5267

  Qin, Qing Hong ^a   Huang, Bai Sha ^b   Tan, Qi Xing ^a   Yang, Wei Ping ^a   Lian, Bin ^a   Wei, Chang Yuan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Guangdong Women and Children Hospital   (China)

Author keywords

125I seed; Animal experimentation; Apoptosis; Hepatocellular carcinoma

Indexed keywords

IODINE 125;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRACHYTHERAPY; CACHEXIA; CANCER INHIBITION; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; HAIR LOSS; HISTOPATHOLOGY; IRRADIATION; LIVER CELL CARCINOMA; LUNG METASTASIS; MOUSE; NECROSIS; NEEDLE; NONHUMAN; PAIN; RADIATION DOSE; RADIOBIOLOGY; SURVIVAL RATE; THORAX WALL; TUMOR VOLUME; ULTRASOUND;

ANIMALIA; MUS;

EID: 84921471818     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jemal A, Bray F, Cetner MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Center MM and Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2011; 20: 2362-2368.
3. Dawson L., McGinn CJ, Normolle D, Ten Haken RK, Walker S, Ensminger W and Lawrence TS. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000; 18: 2210-2218.
4. Klein J and Dawson LA. Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiat Oncol Biol Phys 2013; 87: 22-32.
5. Bujold A and Dawson L. Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma. Cancer/Radiothérapie 2011; 15: 54-63.
6. Bush DA, Kayali Z, Grove R and Slater JD. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial. Cancer 2011; 117: 3053-3059.
7. Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M, Wieners G, Spors B, Werk M and Rosner C. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 2004; 58: 1496-1505.
8. 125I brachytherapy source. Med Phys 2002; 29: 2152-2158.
9. 125I source for interstitial brachytherapy. Med Phys 1993; 20: 1475-1483.
10. Nag S, Beyer D, Friedland J, Grimm P and Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999; 44: 789-799.
11. Zhongmin W, Yu L, Fenju L, Kemin C and Gang H. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Eur Radiol 2010; 20: 1786-1791.
12. Martínez-Monge R, Nag S and Martin EW. Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma. Cancer 1999; 86: 236-247.
13. Nag S, Cano ER, Demanes DJ, Puthawala AA and Vikram B. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2001; 50: 1190-1198.
14. Lee W, Daly BD, DiPetrillo TA, Morelli DM, Neuschatz AC, Morr J and Rivard MJ. Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg 2003; 75: 237-242.
15. Gutin PH, Leibel SA, Wara WM, Choucair A, Levin VA, Philips TL, Silver P, Da Silva V, Edwards MS and Davis RL. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 1987; 67: 864-873.
16. Halligan JB, Stelzer KJ, Rostomily RC, Spence AM, Griffin TW and Berger MS. Operation and permanent low activity 125I brachytherapy for recurrent high-grade astrocytomas. Int J Radiat Oncol Biol Phys 1996; 35: 541-547.
17. Charyulu K, Block N and Sudarsanam A. Preoperative extended field radiation with I-125 seed implant in prostatic cancer: a preliminary report of a randomized study. Int J Radiat Oncol Biol Phys 1979; 5: 1957-1961.
18. Wallner K, Roy J, Zelefsky M, Fuks Z and Harrison L. Short-term freedom from disease progression after I-125 prostate implantation. Int J Radiat Oncol Biol Phys 1994; 30: 405-409.
19. Rosenthal SA, Bittner NH, Beyer DC, Demanes DJ, Goldsmith BJ, Horwitz EM, Ibbott GS, Lee WR, Nag S and Suh WW. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Transperineal Permanent Brachyther-apy of Prostate Cancer. Int J Radiat Oncol Biol Phys 2011; 79: 335-341.
20. Selbach HJ, Bambynek M, Aubineau-Lanièce I, Gabris F, Guerra AS, Toni MP, de Pooter J, Sander T and Schneider T. Experimental determination of the dose rate constant for selected 125I- and 192Ir-brachytherapy sources. Met-rologia 2012; 49: S219.
21. Lo SS, Dawson L., Kim EY, Mayr NA, Wang JZ, Huang Z and Cardenes HR. Stereotactic body radiation therapy for hepatocellular carcinoma. Discov Med 2010; 9: 404-410.
22. Skinner HD, Sharp HJ, Kaseb AO, Javle MM, Vauthey JN, Abdalla EK, Delclos ME, Das P, Crane CH and Krishnan S. Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncol 2011; 50: 1191-1198.
23. Kirov AS and Williamson JF. Monte Carlo-aided dosimetry of the Source Tech Medical Model STM1251 I-125 interstitial brachytherapy source. Med Phys 2001; 28: 764-772.
24. Zhuang HQ, Wang JJ, Liao AY, Wang JD and Zhao Y. The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells. J Exp Clin Canc Res 2009; 28: 12.
25. Huang SM and Harari PM. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. Clinl Cancer Res 2000; 6: 2166-2174.
26. Wilcox JN, Waksman R, King SB and Scott NA. The role of the adventitia in the arterial response to angioplasty: the effect of intravascular radiation. Int J Radiat Oncol Biol Phys 1996; 36: 789-796.